Literature DB >> 26621410

Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis.

Hormuzdiyar H Dasenbrock1, Kevin X Liu1, Christopher A Devine1, Vamsidhar Chavakula1, Timothy R Smith1, William B Gormley1, Ian F Dunn1.   

Abstract

OBJECT Although the length of hospital stay is often used as a measure of quality of care, data evaluating the predictors of extended hospital stay after craniotomy for tumor are limited. The goals of this study were to use multivariate regression to examine which preoperative characteristics and postoperative complications predict a prolonged hospital stay and to assess the impact of length of stay on unplanned hospital readmission. METHODS Data were extracted from the National Surgical Quality Improvement Program (NSQIP) database from 2007 to 2013. Patients who underwent craniotomy for resection of a brain tumor were included. Stratification was based on length of hospital stay, which was dichotomized by the upper quartile of the interquartile range (IQR) for the entire population. Covariates included patient age, sex, race, tumor histology, comorbidities, American Society of Anesthesiologists (ASA) class, functional status, preoperative laboratory values, preoperative neurological deficits, operative time, and postoperative complications. Multivariate logistic regression with forward prediction was used to evaluate independent predictors of extended hospitalization. Thereafter, hierarchical multivariate logistic regression assessed the impact of length of stay on unplanned readmission. RESULTS The study included 11,510 patients. The median hospital stay was 4 days (IQR 3-8 days), and 27.7% (n = 3185) had a hospital stay of at least 8 days. Independent predictors of extended hospital stay included age greater than 70 years (OR 1.53, 95% CI 1.28%-1.83%, p < 0.001); African American (OR 1.75, 95% CI 1.44%-2.14%, p < 0.001) and Hispanic (OR 1.68, 95% CI 1.36%-2.08%) race or ethnicity; ASA class 3 (OR 1.52, 95% CI 1.34%-1.73%) or 4-5 (OR 2.18, 95% CI 1.82%-2.62%) designation; partially (OR 1.94, 95% CI 1.61%-2.35%) or totally dependent (OR 3.30, 95% CI 1.95%-5.55%) functional status; insulin-dependent diabetes mellitus (OR 1.46, 95% CI 1.16%-1.84%); hematological comorbidities (OR 1.68, 95% CI 1.25%-2.24%); and preoperative hypoalbuminemia (OR 1.78, 95% CI 1.51%-2.09%, all p ≤ 0.009). Several postoperative complications were additional independent predictors of prolonged hospitalization including pulmonary emboli (OR 13.75, 95% CI 4.73%-39.99%), pneumonia (OR 5.40, 95% CI 2.89%-10.07%), and urinary tract infections (OR 11.87, 95% CI 7.09%-19.87%, all p < 0.001). The C-statistic of the model based on preoperative characteristics was 0.79, which increased to 0.83 after the addition of postoperative complications. A length of stay after craniotomy for tumor score was created based on preoperative factors significant in regression models, with a moderate correlation with length of stay (p = 0.43, p < 0.001). Extended hospital stay was not associated with differential odds of an unplanned hospital readmission (OR 0.97, 95% CI 0.89%-1.06%, p = 0.55). CONCLUSIONS In this NSQIP analysis that evaluated patients who underwent craniotomy for tumor, much of the variance in hospital stay was attributable to baseline patient characteristics, suggesting length of stay may be an imperfect proxy for quality. Additionally, longer hospitalizations were not found to be associated with differential rates of unplanned readmission.

Entities:  

Keywords:  ACS = American College of Surgeons; ASA = American Society of Anesthesiologists; INR = international normalized ratio; IQR = interquartile range; NSQIP; NSQIP = National Surgical Quality Improvement Program; PTT = partial thromboplastin time; UTI = urinary tract infection; brain tumor; craniotomy; length of hospital stay; outcomes; readmission

Mesh:

Year:  2015        PMID: 26621410     DOI: 10.3171/2015.10.FOCUS15386

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  28 in total

1.  Characteristics and overall survival in pediatric versus adult skull base chordoma: a population-based study.

Authors:  Jordan C Xu; Brandon M Lehrich; Tyler M Yasaka; Brendan M Fong; Frank P K Hsu; Edward C Kuan
Journal:  Childs Nerv Syst       Date:  2021-01-18       Impact factor: 1.475

2.  Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection.

Authors:  Nikita Lakomkin; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2017-12-05       Impact factor: 4.130

3.  The Impact of Race on Discharge Disposition and Length of Hospitalization After Craniotomy for Brain Tumor.

Authors:  Whitney E Muhlestein; Dallin S Akagi; Silky Chotai; Lola B Chambless
Journal:  World Neurosurg       Date:  2017-05-03       Impact factor: 2.104

4.  Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis.

Authors:  David J Cote; Hormuzdiyar H Dasenbrock; William B Gormley; Timothy R Smith; Ian F Dunn
Journal:  World Neurosurg       Date:  2019-05-11       Impact factor: 2.104

5.  Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.

Authors:  Aditya V Karhade; Luis Fandino; Saksham Gupta; David J Cote; Julian B Iorgulescu; Marike L Broekman; Linda S Aglio; Ian F Dunn; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-11-18       Impact factor: 4.130

6.  Resident participation is not associated with postoperative adverse events, reoperation, or prolonged length of stay following craniotomy for brain tumor resection.

Authors:  Nikita Lakomkin; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

7.  Postoperative outcomes following glioblastoma resection using a robot-assisted digital surgical exoscope: a case series.

Authors:  Rebecca B Baron; Nikita Lakomkin; Alexander J Schupper; Dominic Nistal; Kambiz Nael; Gabrielle Price; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2020-06-09       Impact factor: 4.130

Review 8.  Outcome of glioblastoma resection in patients 80 years of age and older.

Authors:  Mahamadou Niare; Jacques Desrousseaux; Clarissa Cavandoli; Victor Virak; Oumar Sacko; Saloua Charni; Franck-Emmanuel Roux
Journal:  Acta Neurochir (Wien)       Date:  2021-03-04       Impact factor: 2.216

9.  Short-Term Morbidity and Predictors of Adverse Events Following Esthesioneuroblastoma Surgery.

Authors:  Khodayar Goshtasbi; Jack L Birkenbeuel; Mehdi Abouzari; Brandon M Lehrich; Tyler M Yasaka; Arash Abiri; Ethan G Muhonen; Frank P K Hsu; Edward C Kuan
Journal:  Am J Rhinol Allergy       Date:  2020-10-29       Impact factor: 2.467

10.  Geriatric Neuro-Oncology in the Middle East: A Sultanate of Oman Experience.

Authors:  Omar Al-Taei; Abdulrahman Al-Mirza; Tariq Al-Saadi
Journal:  Neurol Int       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.